Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer … (NCT06943690) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
China212 participantsStarted 2025-05
Plain-language summary
This study is designed to evaluate the safety and efficacy of single-port robotic surgery compared to multi-port robotic surgery for rectal cancer.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years \< age ≤80 years
* Tumor located in the mid to high rectum (lower edge of tumor ≥ 5 cm from anal verge)
* Pathological rectal carcinoma
* Clinically diagnosed c/ycT1-3N0-1M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual
* Tumor size of 10 cm or less
* No history of other malignant tumors
* ECOG score is 0-1
* ASA score is â… -â…¢
* Informed consent
Exclusion Criteria:
* Body mass index (BMI) \>35 kg/m2
* Familial adenomatous polyposis (FAP)
* Inflammatory bowel disease (IBD)
* Multiple malignant colorectal tumors
* Pregnant woman or lactating woman
* Severe mental disease
* Previous gastrointestinal surgery (except appendectomy )
* Combination of intestinal obstruction, bleeding, perforation requiring emergency surgery
* Requirement of simultaneous surgery for other disease
* Serious disorders of liver and kidney function, coagulation function, or severe underlying diseases that cannot tolerate the surgery.
* Patients or family members who cannot understand the study program.